KR101770321B1 - 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 - Google Patents

폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 Download PDF

Info

Publication number
KR101770321B1
KR101770321B1 KR1020167013476A KR20167013476A KR101770321B1 KR 101770321 B1 KR101770321 B1 KR 101770321B1 KR 1020167013476 A KR1020167013476 A KR 1020167013476A KR 20167013476 A KR20167013476 A KR 20167013476A KR 101770321 B1 KR101770321 B1 KR 101770321B1
Authority
KR
South Korea
Prior art keywords
seq
polypeptide
gastritis
acid sequence
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020167013476A
Other languages
English (en)
Korean (ko)
Other versions
KR20160064237A (ko
Inventor
리사 엘. 헤론-올슨
드류 엠. 카트론
Original Assignee
이피토픽스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이피토픽스, 엘엘씨 filed Critical 이피토픽스, 엘엘씨
Publication of KR20160064237A publication Critical patent/KR20160064237A/ko
Application granted granted Critical
Publication of KR101770321B1 publication Critical patent/KR101770321B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/38—Antigens from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020167013476A 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 Expired - Fee Related KR101770321B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21077209P 2009-03-23 2009-03-23
US61/210,772 2009-03-23
PCT/US2010/028326 WO2010111273A1 (en) 2009-03-23 2010-03-23 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020117025065A Division KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Publications (2)

Publication Number Publication Date
KR20160064237A KR20160064237A (ko) 2016-06-07
KR101770321B1 true KR101770321B1 (ko) 2017-09-05

Family

ID=42781438

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020167013476A Expired - Fee Related KR101770321B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167026534A Ceased KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020117025065A Ceased KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020157018079A Expired - Fee Related KR101684292B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020167026534A Ceased KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020117025065A Ceased KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020157018079A Expired - Fee Related KR101684292B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Country Status (14)

Country Link
US (2) US9932373B2 (enExample)
EP (1) EP2411046B1 (enExample)
JP (2) JP2012521441A (enExample)
KR (4) KR101770321B1 (enExample)
CN (1) CN105582524A (enExample)
AR (1) AR075933A1 (enExample)
AU (1) AU2016201992B2 (enExample)
BR (1) BRPI1011856A2 (enExample)
CA (1) CA2756313A1 (enExample)
IL (2) IL215330A (enExample)
MX (1) MX339461B (enExample)
NZ (2) NZ595231A (enExample)
WO (1) WO2010111273A1 (enExample)
ZA (1) ZA201106959B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0607323B8 (pt) 2005-02-14 2021-05-25 Epitopix Llc composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
AU2013202253B2 (en) * 2009-04-14 2015-03-19 Novartis Ag Compositions for immunising against Staphylococcus aureus
US9724658B2 (en) * 2011-03-28 2017-08-08 Fast & Fluid Management B.V. Method of homogenizing a liquid
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
US20170023569A1 (en) * 2014-01-10 2017-01-26 University Of Rochester Diagnostic device and method for detection of staphylococcus infection
CA2991907A1 (en) * 2015-07-10 2017-01-19 Douglas T. Burkhardt Proteins and immunizing compositions containing klebsiella proteins and methods of use
TW201819402A (zh) 2016-10-21 2018-06-01 加拿大商索克普拉科學與工程公司 對抗葡萄球菌感染之疫苗構築體及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115490A1 (en) * 2001-03-27 2006-06-01 Vega Masignani Staphylococcus aureus proteins and nucleic acids
US20080200650A1 (en) 2005-02-14 2008-08-21 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
CA2182976C (en) 1994-02-09 2011-07-12 Daryll A. Emery Active immunization using a siderophore receptor protein
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
WO1997043314A2 (en) 1996-05-16 1997-11-20 The Texas A & M University System Collagen binding protein compositions and methods of use
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
EP1268774A2 (en) * 2000-03-21 2003-01-02 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
WO2002053180A2 (en) 2001-01-03 2002-07-11 Willmar Poultry Company, Inc. Immunizing compositions and methods of use
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
EP2320233A1 (en) 2001-06-15 2011-05-11 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
AU2002353764A1 (en) 2001-06-17 2003-03-18 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
AU2003254555A1 (en) 2002-07-26 2004-02-23 Intercell Ag S. aureus antigene
BRPI0414267A (pt) 2003-09-19 2006-11-21 Epitopix Llc polipeptìdeos de campilobacter e métodos de uso
WO2005103073A2 (en) 2004-04-27 2005-11-03 Intercell Ag Td antigens
EP1784220B1 (en) 2004-08-26 2017-12-20 The University Of Western Ontario Bacterial iron acquisition targets
CA2581746A1 (en) * 2004-10-25 2006-06-08 The University Of Western Ontario Staphylococcus aureus isd protein-based anti-infectives
US8021885B2 (en) 2006-10-11 2011-09-20 Evonik Rohmax Additives Gmbh Method for the determination of the oxidative stability of a lubricating fluid
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115490A1 (en) * 2001-03-27 2006-06-01 Vega Masignani Staphylococcus aureus proteins and nucleic acids
US20080200650A1 (en) 2005-02-14 2008-08-21 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Also Published As

Publication number Publication date
US20180237481A1 (en) 2018-08-23
KR101684292B1 (ko) 2016-12-08
AU2010229498A1 (en) 2011-10-13
BRPI1011856A2 (pt) 2020-11-03
EP2411046A1 (en) 2012-02-01
EP2411046B1 (en) 2017-12-06
CN105582524A (zh) 2016-05-18
US9932373B2 (en) 2018-04-03
IL248523A0 (en) 2016-12-29
CN102448489A (zh) 2012-05-09
NZ595231A (en) 2014-03-28
IL215330A (en) 2016-12-29
AU2016201992B2 (en) 2018-02-15
KR20160064237A (ko) 2016-06-07
KR20160114744A (ko) 2016-10-05
EP2411046A4 (en) 2012-09-19
JP2012521441A (ja) 2012-09-13
US20120034258A1 (en) 2012-02-09
MX339461B (es) 2016-05-27
JP2015164949A (ja) 2015-09-17
AU2016201992A1 (en) 2016-04-21
CA2756313A1 (en) 2010-09-30
KR20150093774A (ko) 2015-08-18
WO2010111273A1 (en) 2010-09-30
NZ614557A (en) 2015-03-27
KR20120005471A (ko) 2012-01-16
JP6092933B2 (ja) 2017-03-08
AR075933A1 (es) 2011-05-04
MX2011009949A (es) 2011-10-06
ZA201106959B (en) 2012-06-27
IL215330A0 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
AU2016201992B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
US9981028B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU2010229498B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
CN102448489B (zh) 多肽和含有革兰氏阳性多肽的免疫组合物及使用方法
AU2015258239B2 (en) Polypeptides from staphylococcus aureus and methods of use
AU2012244060B2 (en) Polypeptides from staphylococcus aureus and methods of use

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

Not in force date: 20200817

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20200817

St.27 status event code: N-4-6-H10-H13-oth-PC1903